相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cancer Statistics, 2021
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Focal Boost to the Intraprostatic Tumor in External Beam Radiotherapy for Patients With Localized Prostate Cancer: Results From the FLAME Randomized Phase III Trial
Linda G. W. Kerkmeijer et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Magnetic Resonance-guided Stereotactic Radiotherapy for Localized Prostate Cancer: Final Results on Patient-reported Outcomes of a Prospective Phase 2 Study
Shyama U. Tetar et al.
EUROPEAN UROLOGY ONCOLOGY (2021)
Primary endpoint analysis of the multicentre phase II hypo-FLAME trial for intermediate and high risk prostate cancer
Cedric Draulans et al.
RADIOTHERAPY AND ONCOLOGY (2020)
Stereotactic Body Radiation Therapy for Localized Prostate Cancer: A Systematic Review and Meta-Analysis of Over 6,000 Patients Treated On Prospective Studies
William C. Jackson et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2019)
Using adaptive magnetic resonance image-guided radiation therapy for treatment of inoperable pancreatic cancer
Soumon Rudra et al.
CANCER MEDICINE (2019)
A Prospective Single-Arm Phase 2 Study of Stereotactic Magnetic Resonance Guided Adaptive Radiation Therapy for Prostate Cancer: Early Toxicity Results
Anna M. E. Bruynzeel et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2019)
Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial
Anders Widmark et al.
LANCET (2019)
Intensity-modulated fractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): acute toxicity findings from an international, randomised, open-label, phase 3, non-inferiority trial
Douglas H. Brand et al.
LANCET ONCOLOGY (2019)
Technical design and concept of a 0.35 T MR-Linac
Sebastian Klueter
CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY (2019)
MRI guided stereotactic radiotherapy for locally advanced pancreatic cancer
Hanne D. Heerkens et al.
BRITISH JOURNAL OF RADIOLOGY (2018)
OneArmPhaseTwoStudy: An R Package for Planning, Conducting, and Analysing Single-Arm Phase II Studies
Meinhard Kieser et al.
JOURNAL OF STATISTICAL SOFTWARE (2017)
Fast and robust online adaptive planning in stereotactic MR-guided adaptive radiation therapy (SMART) for pancreatic cancer
O. Bohoudi et al.
RADIOTHERAPY AND ONCOLOGY (2017)
UK Consensus on Normal Tissue Dose Constraints for Stereotactic Radiotherapy
G.G. Hanna et al.
CLINICAL ONCOLOGY (2017)
PI-RADS Prostate Imaging - Reporting and Data System: 2015, Version 2
Jeffrey C. Weinreb et al.
EUROPEAN UROLOGY (2016)
Randomized Phase III Noninferiority Study Comparing Two Radiotherapy Fractionation Schedules in Patients With Low-Risk Prostate Cancer
W. Robert Lee et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Hypofractionated versus conventionally fractionated radiotherapy for patients with localised prostate cancer (HYPRO): final efficacy results from a randomised, multicentre, open-label, phase 3 trial
Luca Incrocci et al.
LANCET ONCOLOGY (2016)
Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial
David Dearnaley et al.
LANCET ONCOLOGY (2016)
The ViewRay System: Magnetic Resonance-Guided and Controlled Radiotherapy
Sasa Mutic et al.
SEMINARS IN RADIATION ONCOLOGY (2014)
Meta-analysis of the Alpha/Beta Ratio for Prostate Cancer in the Presence of an Overall Time Factor: Bad News, Good News, or No News?
Ivan R. Vogelius et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2013)
Randomized Trial of Hypofractionated External-Beam Radiotherapy for Prostate Cancer
Alan Pollack et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Stereotactic Body Radiation Therapy (SBRT) for clinically localized prostate cancer: the Georgetown University experience
Leonard N. Chen et al.
RADIATION ONCOLOGY (2013)
Stereotactic body radiotherapy for localized prostate cancer: Pooled analysis from a multi-institutional consortium of prospective phase II trials
Christopher R. King et al.
RADIOTHERAPY AND ONCOLOGY (2013)
Prostate alpha/beta revisited - an analysis of clinical results from 14 168 patients
Alexandru Dasu et al.
ACTA ONCOLOGICA (2012)
Hypofractionated stereotactic body radiotherapy in low-risk prostate adenocarcinoma
Sean M. McBride et al.
CANCER (2012)
LONG-TERM OUTCOMES FROM A PROSPECTIVE TRIAL OF STEREOTACTIC BODY RADIOTHERAPY FOR LOW-RISK PROSTATE CANCER
Christopher R. King et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2012)
Acute Toxicity After CyberKnife-Delivered Hypofractionated Radiotherapy for Treatment of Prostate Cancer
Natasa C. Townsend et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2011)
CONFIRMATION OF A LOW alpha/beta RATIO FOR PROSTATE CANCER TREATED BY EXTERNAL BEAM RADIATION THERAPY ALONE USING A POST-TREATMENT REPEATED-MEASURES MODEL FOR PSA DYNAMICS
Cecile Proust-Lima et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2011)
Dose-Fractionation Sensitivity of Prostate Cancer Deduced From Radiotherapy Outcomes of 5,969 Patients in Seven International Institutional Datasets: α/β = 1.4 (0.9–2.2) Gy
Raymond Miralbell et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2011)
The role of overall treatment time in the outcome of radiotherapy of prostate cancer: An analysis of biochemical failure in 4839 men treated between 1987 and 1995
Howard D. Thames et al.
RADIOTHERAPY AND ONCOLOGY (2010)
HIGHER-THAN-CONVENTIONAL RADIATION DOSES IN LOCALIZED PROSTATE CANCER TREATMENT: A META-ANALYSIS OF RANDOMIZED, CONTROLLED TRIALS
Gustavo Arruda Viani et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2009)
Stereotactic hypofractionated accurate radiotherapy of the prostate (SHARP), 33.5 Gy in five fractions for localized disease: First clinical trial results
Berit L. Madsen et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2007)
Admissible two-stage designs for phase II cancer clinical trials
SH Jung et al.
STATISTICS IN MEDICINE (2004)
Is α/β for prostate tumors really low?
J Fowler et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2001)
分享论文
